Tyche Industries Limited announced its unaudited financial results for the third quarter and nine months ended December 31, 2025, revealing a challenging performance with significant year-on-year declines in profitability. The API-focused company reported substantial drops in both revenue and net profit during the quarter.

Financial Performance Overview

The company's financial metrics for Q3FY26 showed considerable pressure compared to the previous year:

Revenue Composition and Operational Metrics

The company's revenue structure for Q3FY26 comprised entirely of other operating income of ₹1,057.93 lakhs and other income of ₹185.16 lakhs. This represents a significant shift from Q3FY25 when other operating income stood at ₹1,775.10 lakhs and other income was ₹204.23 lakhs.

Total expenses decreased by 25.7% to ₹997.18 lakhs in Q3FY26 from ₹1,341.39 lakhs in the corresponding quarter of the previous year. The expense reduction was primarily driven by changes in inventories and cost management measures across various operational categories.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the company's performance showed similar declining trends:

Sequential Quarter Improvement

Despite the year-on-year decline, Tyche Industries showed sequential improvement in Q3FY26. Net profit increased 19.6% from ₹152.30 lakhs in Q2FY26, while total income declined from ₹1,680.94 lakhs to ₹1,243.10 lakhs quarter-on-quarter.

Business Segment and Market Presence

The company operates exclusively in the Active Pharmaceutical Ingredients (APIs) segment. During the nine-month period, export sales contributed ₹3,390.55 lakhs while domestic sales accounted for ₹353.32 lakhs, highlighting the company's significant export orientation.

Corporate Governance and Compliance

The Board of Directors approved these unaudited financial results at their meeting held on February 12, 2026. The results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by the Audit Committee. The statutory auditors P.S.N. Ravishanker & Associates conducted a limited review of the financial results.

The company maintains its paid-up equity share capital at ₹1,024.53 lakhs with a face value of ₹10 per share, remaining unchanged across all reported periods.

Source: Exclusive

Tyche Industries Limited , a prominent player in the Indian pharmaceutical sector, has commenced its dividend distribution for the financial year 2024-25. The company has declared a dividend of 30% on the face value of its equity shares, translating to Rs 3.00 per share.

Dividend Details

The dividend payments, which began on October 10, 2025, are being distributed to shareholders whose names appeared on the company's register of members as of the record date, September 19, 2025.

Official Communication

In an official communication to the BSE Limited on October 14, 2025, Tyche Industries confirmed the initiation of the dividend payout. Pradosh Ranjan Jena, the Company Secretary & Compliance Officer, stated in the letter, "The Company has started the payment of the Dividend for the financial year 2024-25 from 10th October, 2025 to all the members whose name appear on the Register of members as on the record date i.e., 19th September 2025."

This dividend declaration demonstrates Tyche Industries' commitment to delivering value to its shareholders. It also reflects the company's financial performance and its policy of sharing profits with investors.

Shareholders of Tyche Industries Limited can expect to receive their dividend payments through their registered payment methods. Those who haven't yet received their dividends may want to ensure their bank details are up to date with their respective depository participants or the company's registrar.

As always, investors are advised to consider dividend announcements as part of their overall investment strategy and to consult with financial advisors for personalized advice.